|
UEVLD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02520000266892E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.56549997807087E-09 |
| Normal-vs-Stage2 |
4.177700E-03 |
| Normal-vs-Stage3 |
5.477700E-03 |
| Normal-vs-Stage4 |
1.8207999999964E-06 |
| Stage1-vs-Stage2 |
5.271200E-01 |
| Stage1-vs-Stage3 |
2.552800E-01 |
| Stage1-vs-Stage4 |
3.743800E-01 |
| Stage2-vs-Stage3 |
7.687400E-01 |
| Stage2-vs-Stage4 |
2.138000E-01 |
| Stage3-vs-Stage4 |
1.486770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.88400000045164E-08 |
| Normal-vs-AfricanAmerican |
2.02119999959116E-07 |
| Normal-vs-Asian |
1.485630E-02 |
| Caucasian-vs-AfricanAmerican |
6.184400E-01 |
| Caucasian-vs-Asian |
8.997000E-01 |
| AfricanAmerican-vs-Asian |
7.544800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.34540054044885E-10 |
| Normal-vs-Female |
1.239790E-02 |
| Male-vs-Female |
1.002930E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.11619999998425E-06 |
| Normal-vs-Extreme_Weight |
4.96229723978558E-11 |
| Normal-vs-Obese |
1.202740E-04 |
| Normal-vs-Extreme_Obese |
5.046500E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.074400E-01 |
| Normal_Weight-vs-Obese |
2.553400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.919000E-01 |
| Extreme_Weight-vs-Obese |
2.660200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.301800E-01 |
| Obese-vs-Extreme_Obese |
5.051400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.073400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.55460000001484E-07 |
| Normal-vs-Age(61-80Yrs) |
7.25259963196834E-10 |
| Normal-vs-Age(81-100Yrs) |
8.58950000015568E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.047230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.388280E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.991900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.870300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.494630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.626200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.31419986004744E-10 |
| Normal-VS-Type2 PRCC |
3.68790000004893E-06 |
| Normal-VS-KIRP CIMP |
9.368600E-01 |
| Normal-VS-Unclassified PRCC |
5.055900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.047170E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.358300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.752300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.667900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.953790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.702000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.60370000004784E-08 |
| Normal-vs-N1 |
2.882400E-02 |
| Normal-vs-N2 |
3.177400E-03 |
| N0-vs-N1 |
9.298000E-02 |
| N0-vs-N2 |
8.019800E-01 |
| N1-vs-N2 |
3.930600E-01 |
|
|
